Skip to main content

Table 2 Odds ratios for decreased eGFR according to triglyceride level and waist circumference

From: Association of hypertriglyceridemic waist phenotype with renal function impairment: a cross-sectional study in a population of Chinese adults

Variables Cases/Participants Model 1a P value Model 2b P value Model 3c P value
OR (95% CI) OR (95% CI) OR (95% CI)
Decreased eGFR
 NTNW 213/13,905 1.00   1.00   1.00  
 NTGW 273/7197 1.94 (1.60–2.35) <  0.001 1.94 (1.60–2.34) <  0.001 1.75 (1.41–2.18) <  0.001
 HTNW 109/4806 1.55 (1.22–1.96) <  0.001 1.55 (1.23–1.96) <  0.001 1.29 (0.99–1.68) 0.060
 HTGW 234/5388 2.54 (2.09–3.09) <  0.001 2.55 (2.09–3.10) <  0.001 1.99 (1.54–2.58) <  0.001
P-trend   <  0.001   <  0.001   <  0.001  
Decreased eGFRMDRD
 NTNW 351/13,905 1.00   1.00   1.00  
 NTGW 402/7197 1.81 (1.56–2.11) <  0.001 1.82 (1.56–2.12) <  0.001 1.79 (1.50–2.13) <  0.001
 HTNW 150/4806 1.24 (1.02–1.51) 0.029 1.24 (1.02–1.51) 0.029 1.11 (0.89–1.39) 0.348
 HTGW 316/5388 2.07 (1.77–2.43) <  0.001 2.09 (1.78–2.45) <  0.001 1.88 (1.52–2.34) <  0.001
P-trend   <  0.001   <  0.001   <  0.001  
  1. eGFR Estimated glomerular filtration rate, OR Odds ratio, CI Confidence interval, MDRD Modification of Diet in Renal Disease, NWNT Normal triglyceride level (< 1.7 mmol/L) and normal waist circumference (< 90 cm for men and < 80 cm for women), NTGW Normal triglyceride level and enlarged waist circumference (≥90 cm for men and ≥ 80 cm for women), HTNW Elevated triglyceride level (≥1.7 mmol/L) and normal waist circumference, HTGW Elevated triglyceride level and enlarged waist circumference
  2. aAdjusted for age and sex
  3. bAdjusted for model 1 covariates plus marital status, educational level, working status, smoking status, alcohol consumption, and physical activity
  4. cAdjusted for model 2 covariates plus body mass index, hypertension, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol, and T2DM